Hanrahan Jessie
Chief Regulatory Officer
Hanrahan Jessie has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Hanrahan Jessie is listed as Chief Regulatory Officer at Solid Biosciences Inc. Inside the rolling window, Hanrahan Jessie reported no open-market purchases and 4 open-market sales totaling $297K in SLDB. The largest disclosed transaction in the window is a sale of 26,535 SLDB shares on Feb 2, 2026, worth $171K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$297K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hanrahan Jessie made?
Hanrahan Jessie has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Hanrahan Jessie trade?
Hanrahan Jessie has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Hanrahan Jessie's most recent SEC Form 4 filing?
Hanrahan Jessie's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Hanrahan Jessie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hanrahan Jessie is listed as Chief Regulatory Officer.
What is Hanrahan Jessie's total buy and sell value in the current window?
Inside the rolling retention window, Hanrahan Jessie bought $0 and sold $297K based on SEC Form 4 filings.
What was Hanrahan Jessie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 26,535 SLDB shares on 2026-02-02, worth $171K, per SEC Form 4 filings.